logo-loader
NASDAQ:IOVA

Iovance Biotherapeutics

Receive alerts
Market:
NASDAQ
Market Cap:
$2.57 billion
Price
$20.78
Change
-1.93%
52 weeks high
26.55
52 weeks low
7.27

In brief

IOVANCE Biotherapeutics is focused on the development and commercialization of autologous cellular immunotherapies optimizing personalized, tumor-directed Tumor Infiltrating Lymphocytes (TIL).